190 filings
Page 5 of 10
8-K
bqn3d3ru93j84axgjcku
19 Feb 21
AbbVie, Evolus, and Medytox Announce Resolution of Intellectual Property Litigation
9:17am
8-K
owuv ug4tawx
16 Feb 21
Regulation FD Disclosure
9:00am
8-K
5o8sial0izwzl l1dl
5 Jan 21
Termination of a Material Definitive Agreement
8:30am
8-K
qnv30f64f0
16 Dec 20
Evolus Provides Update on United States International Trade Commission (ITC) Case
5:07pm
8-K
g236uyoqu0ec3ug3b
19 Nov 20
Regulation FD Disclosure
5:03pm
8-K
0go eig4egkokanlsdj
29 Oct 20
Evolus Reports Third Quarter 2020 Results and Provides Business Update
4:22pm
8-K
pfy8m0ygfgxlqz58
22 Oct 20
Regulation FD Disclosure
4:28pm
8-K
ykh68gpsin7bl0 ka
10 Aug 20
Evolus Reports Second Quarter 2020 Results and Provides Business Update
4:06pm
D
mia1 sjxl
16 Jul 20
$40M in Convertible Promissory Note, sold $40M, 1 investor
9:31pm
8-K
9hihggn
7 Jul 20
Evolus Provides Update on International Trade Commission (ITC) Case
9:24am
8-K
qxlhob33pjrxz
2 Jun 20
Regulation FD Disclosure
9:00am
8-K
awg74 qw79qeczc
11 May 20
Evolus Reports First Quarter 2020 Results and Provides Business Update
4:01pm
8-K
0lrirr75ncctnz mp
4 May 20
Submission of Matters to a Vote of Security Holders
4:22pm
DEFA14A
ehwrwcrxazwdmj
21 Apr 20
Additional proxy soliciting materials
4:13pm
8-K
xub50 hfpl
16 Apr 20
Evolus Provides Strategic Business Update
4:53pm
DEFA14A
zxh mcbui0pu
17 Mar 20
Additional proxy soliciting materials
4:48pm